← Back to Search

Behavioral Intervention

ACTaide Mobile App for Psychological Distress

N/A
Waitlist Available
Led By Bärbel Knäuper, PhD
Research Sponsored by Barbel Knauper
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be at least 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in distress tolerance will be measured from baseline to the two-week, post-intervention time point and from baseline to the four-week, follow-up time point.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new mobile app called ACTaide that helps people practice mindfulness exercises. The app uses images to guide users through the exercises step by step. The study aims to see if the

Who is the study for?
This trial is for Canadian adults experiencing psychological distress. Participants must be willing to use a mobile app and attend an online psychoeducational workshop. They should have access to the internet and a smartphone.
What is being tested?
The study tests ACTaide, a new mobile app designed to help users practice mindfulness exercises from Acceptance and Commitment Therapy (ACT). It's compared with a control group using just reminders. The focus is on how well participants stick with the program, like the app, and continue in the study.
What are the potential side effects?
Since this trial involves non-invasive interventions such as using mobile apps for mindfulness practices, significant side effects are not anticipated. However, some individuals might experience discomfort or emotional distress when engaging in mindfulness exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
ACTaide mobile app acceptability
Intervention adherence (home practice of mindfulness exercise)
Participant retention
Secondary study objectives
Changes in Distress Tolerance
Changes in Mindfulness Skills
Changes in Symptoms of Depression, Anxiety, Stress

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACT Workshop Plus ACTaide Mobile AppExperimental Treatment2 Interventions
In this condition, participants will attend a 1-hour virtual ACT psychoeducational workshop where they will learn about ACT, practice the dropping anchor exercise (with a guided image sequence), and learn how to use the ACTaide mobile app, which they will be asked to use to practice the dropping anchor exercise daily for two weeks. The main feature of the ACTaide app is the annotated image sequence to guide users through the steps of the exercise. The app also features customizable reminders notifications. Participants will receive three reminders per day encouraging them to practice the exercise.
Group II: ACT Workshop Plus Reminders-only Mobile AppActive Control2 Interventions
In this condition, participants will attend a 1-hour virtual ACT psychoeducational workshop where they will learn about ACT, practice the dropping anchor exercise (without a guided image sequence), and learn how to use the reminders-only mobile app, which they will be asked to use to practice the dropping anchor exercise daily for two weeks. This app will not include the annotated image sequence from ACTaide and instead will only include customizable reminders notifications. Participants will receive three reminders per day encouraging them to practice the exercise.

Find a Location

Who is running the clinical trial?

Barbel KnauperLead Sponsor
Bärbel Knäuper, PhDPrincipal InvestigatorMcGill University
2 Previous Clinical Trials
119 Total Patients Enrolled
~26 spots leftby May 2025